Indinavir
123 interactions 10 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Dihydroergotamine Injection
Finerenone
Ivabradine
Colchicine
Lovastatin
Lurasidone
Contraindicated
Indinavir Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Indinavir Simvastatin Flolipid Explained Increased simvastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Indinavir Alfuzosin UroXatral Increased alfuzosin plasma concentrations Details Indinavir Dihydroergotamine Injection DHE-45® Injection Increased ergot derivative exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Indinavir Dihydroergotamine Nasal Spray Migranal Increased ergot derivative exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Indinavir Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Indinavir Ivabradine Corlanor Increased ivabradine exposure and an increased risk of ivabradine-related adverse effects [like bradycardia and conduction disturb... Details Indinavir Lovastatin Altocor® Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Indinavir Lurasidone Latuda Increased lurasidone exposure Details Indinavir Methylergonovine Methergine Increased ergot derivative exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Indinavir Midazolam Nasal Spray Nayzilam Increased midazolam plasma concentrations Details Indinavir Midazolam Injection Nayzilam Increased midazolam plasma concentrations Details Indinavir Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details Indinavir Nimodipine Nimotop Increased plasma concentrations of nimodipine DetailsMajor
Indinavir Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Indinavir Omeprazole Gastrobim Explained Reduced indinavir exposure with reduced efficacy Details Indinavir Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Indinavir Relugolix Orgovyx Explained Increased relugolix exposure Details Indinavir Acalabrutinib Calquence Increased acalabrutinib exposure Details Indinavir Ado-Trastuzumab Emtansine Injection KADCYLA Increased exposure of cytotoxic component DM1 (maytansine derivative) and risk of toxicity Details Indinavir Apixaban Eliquis Explained Increased apixaban exposure and an increased risk of bleeding Details Indinavir Aripiprazole Injection Abilify Increased ARIPiprazole exposure Details Indinavir Asciminib Scemblix Increased asciminib exposure and an increased risk of asciminib-related adverse effects Details Indinavir Atogepant Qulipta Increased atogepant exposure Details Indinavir Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Indinavir Atorvastatin Atorvaliq Increased plasma levels of atorvastatin and an increased risk of myopathy or rhabdomyolysis Details Indinavir Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Indinavir Avanafil Stendra Decreased avanafil clearance and increased avanafil plasma concentration Details Indinavir Axitinib Inlyta Increased axitinib plasma concentrations Details Indinavir Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Indinavir Beclomethasone Oral Inhalation Beclovent® Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Indinavir Bedaquiline Sirturo Increased bedaquiline exposure Details Indinavir Bosutinib Bosulif Increased bosutinib exposure Details Indinavir Brentuximab Vedotin Injection Adcetris Increased exposure to active entity of brentuximab vedotin Details Indinavir Brexpiprazole Rexulti Increased brexpiprazole exposure Details Indinavir Brigatinib Alunbrig Increased brigatinib exposure Details Indinavir Budesonide Entocort Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Indinavir Budesonide Nasal Spray Rhinocort Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Indinavir Budesonide Oral Inhalation Pulmicort Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Indinavir Cabazitaxel Injection Jevtana Increased cabazitaxel exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.